Pharmaceuticals
10 pharmaceutical technology transfer experts
These ten professionals have held technology transfer roles at pharmaceutical companies, with titles such as Technology Transfer Manager and Head of Global Tech Transfer. A reader can learn how pharmaceutical companies transfer processes and products into manufacturing sites.
Professionals to explore
01—10Barbara Gallego Exposito
LinkedInExperience: Technology Transfer Manager · Chemo
Former Technology Transfer Manager (2020–2026) and Technology Transfer Team Leader (2014–2020) at Chemo, and Universal Farma Site Associate Director at Chemo since 2026. For the manager role, the profile describes leading end-to-end technology transfer projects for pharmaceutical products and manufacturing processes across internal sites, external partners and Contract Manufacturing Organizations (CMOs).
Carin M. Kahr
LinkedInExperience: Head of Global Tech Transfer · Biogen
Former Head of Global Tech Transfer (2022–2023) and Senior Manager, Tech Transfer (2020–2022) at Biogen, and Senior Director, MSAT at Veloxis Pharmaceuticals, Inc. since 2026. The profile describes expertise in process development, manufacturing sciences and process engineering, and lists Associate Director, MSAT at AskBio Inc. (2023–2026).
Catherine Watkins
LinkedInExperience: Head of Global MSAT Tech Transfer and Program Management · Takeda
Head of Global MSAT Tech Transfer and Program Management at Takeda since 2026, with Global Head of Product Quality & LCM, Biologics Operating Unit at Takeda also listed since 2025. The profile describes leading enterprise governance and execution for complex technology transfers across all modalities, from development through commercialization.
Cecilia Goncalves
LinkedInExperience: Analytical Transfer Leader · Sanofi
Analytical Transfer Leader at Sanofi since 2022, a role the profile places within the Tech Transfer, MSAT department and describes as responsible for technical process and analytical transfer projects, including defining and leading analytical transfer strategy with sending and receiving units. The profile also lists Product and Process Specialist - seed and international Influenza vaccine at Sanofi (2019–2022).
Glenn Loos
LinkedInExperience: Technology Tranfer Lead · Sanofi
Technology Tranfer Lead at Sanofi since 2025, a role the profile describes as overseeing the transfer of processes and technologies from development to internal manufacturing sites or from Sanofi to CMOs. The profile also lists MSAT Process Engineer - Tech Transfer (2018–2019) and MSAT senior process engineer - Downstream Purification (2019–2025) at Sanofi.
Kevin Bai
LinkedInExperience: Technology Transfer Leader - MSAT · Sanofi
Technology Transfer Leader - MSAT at Sanofi since 2024. The profile describes hands-on experience and knowledge of CMC drug substance and drug product development, tech transfer and the approval process in the pharma and biotech industry, and lists Associate Director - Process Development at Aurinia Pharmaceuticals Inc. (2022–2024).
Litza Montalvan
LinkedInExperience: MSAT Technology Transfer Strategy Lead · Johnson & Johnson Innovative Medicine
MSAT Technology Transfer Strategy Lead at Johnson & Johnson Innovative Medicine since 2025. The profile also lists Technical Operations Senior Manager - Site Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson (2015–2024), Manufacturing Manager there (2013–2015) and Associate Director Strategic Planning at AbbVie (2024–2025).
Moon‐Sun Jang
LinkedInExperience: Global MSAT - Technical Launch Integrator (Tech transfer of Protein DP and vaccines) · Johnson & Johnson Innovative Medicine
Former Global MSAT - Technical Launch Integrator (Tech transfer of Protein DP and vaccines) at Johnson & Johnson Innovative Medicine (2017–2021), and MSAT Synthetic DP APAC Sites Director there since 2026. The profile cites strength in project management and technology transfer and end to end experience of injections (protein DP) from sourcing decision to technology transfer, and lists Site MSAT lead - Associate Director (2021–2026).
Pranavan Thillaivinayagalingam
LinkedInExperience: Director, Technology Transfer Biologics Global MSAT · Merck Group
Former Director, Technology Transfer Biologics Global MSAT at Merck Group (2020–2025), and Head of Manufacturing Science and Technology (MSAT) - DS, DP & FP at Merck Group since 2025. The profile describes experience in process and technology transfer, characterisation and validation of late stage biopharmaceutical processes, and lists Head of Drug Substance Global MSAT at Merck Group (2020–2021).
Thomas Hadamzyk
LinkedInExperience: Associate Director Technology Transfer Product Supply · BioNTech SE
Former Associate Director Technology Transfer Product Supply at BioNTech SE (2022–2024), and Director Global MSAT Strategy & Operations Product Supply at BioNTech SE since 2024. The profile also lists Advanced Expert Transfer&Launch (MSAT) Pharma Global Technical Operations at Roche (2020–2022) and describes technology transfer and manufacturing strategy roles for DS and DP manufacturing across mRNA, CGT and biologics.
Choose the right perspective
Match the person's modality to yours, since biologics, vaccines, cell and gene therapies and small molecules transfer in different ways. For hands-on questions about running a single transfer, favor someone in a transfer lead role, and for questions about governing a portfolio of transfers across sites, favor someone with a global or head-of-function scope.
Questions to take into the conversation
- 01What do you need in place before a technology transfer starts, and what most often gets missed?
- 02How do you divide responsibilities between the sending and receiving sites, and how do you resolve disagreements?
- 03How do you decide when a transfer is complete and the receiving site is ready for validation batches?
Reaching pharmaceutical technology transfer experts
How can I contact one of these pharmaceutical technology transfer experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 7 companies, including Chemo, Biogen and Takeda, based on profile data retrieved on October 4, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach pharmaceutical technology transfer experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal